These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 34108465)

  • 1. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.
    Yang B; Fan J; Huang J; Guo E; Fu Y; Liu S; Xiao R; Liu C; Lu F; Qin T; He C; Wang Z; Qin X; Hu D; You L; Li X; Wang T; Wu P; Chen G; Zhou J; Li K; Sun C
    Nat Commun; 2021 Jun; 12(1):3501. PubMed ID: 34108465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence.
    La Sala L; Gandini S; Bruno A; Allevi R; Gallazzi M; Senesi P; Palano MT; Meregalli P; Longhi E; Sommese C; Luzi L; Trabucchi E
    Front Immunol; 2022; 13():798813. PubMed ID: 35237261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
    You M; Chen L; Zhang D; Zhao P; Chen Z; Qin EQ; Gao Y; Davis MM; Yang P
    Nat Cell Biol; 2021 Jun; 23(6):620-630. PubMed ID: 34108657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12.
    Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C
    Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
    Rutkowska E; Kwiecień I; Żabicka M; Maliborski A; Raniszewska A; Kłos K; Urbańska W; Klajnowicz I; Rzepecki P; Chciałowski A
    Viruses; 2021 May; 13(5):. PubMed ID: 34064802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
    Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
    Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity.
    Dai W; Zhong A; Qiao Q; Wu J; Li W; Wu Q; Zhou H; Qin S; Jiang W; Zhang J; Xia X
    Virol J; 2022 Nov; 19(1):192. PubMed ID: 36403042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
    Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q
    Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of respiratory dendritic cell subsets and lymphocyte populations in inbred mouse strains.
    Hackstein H; Wachtendorf A; Kranz S; Lohmeyer J; Bein G; Baal N
    Respir Res; 2012 Oct; 13(1):94. PubMed ID: 23066782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.